Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain.
Hill
J M
JM
Section on Molecular and Developmental Pharmacology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
Mervis
R F
RF
Politi
J
J
McCune
S K
SK
Gozes
I
I
Fridkin
M
M
Brenneman
D E
DE
D000375:Aging / Q000378:metabolism*; D000818:Animals; D000831:Animals, Newborn; D001345:Autoradiography; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D015870:Gene Expression / Q000187:drug effects; D017403:In Situ Hybridization; D007457:Iodine Radioisotopes; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009928:Organ Specificity; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D017207:Rats, Sprague-Dawley; D018005:Receptors, Vasoactive Intestinal Peptide / Q000096:biosynthesis*; D012016:Reference Values; D014660:Vasoactive Intestinal Peptide / Q000037:antagonists & inhibitors* / Q000096:biosynthesis* / Q000494:pharmacology
D007457:Iodine Radioisotopes; D012333:RNA, Messenger; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide